Skip to content
2000
Volume 28, Issue 15
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background

Verbascoside, a compound classified as a phenylethanol glycoside in Dihuang, has been the subject of modern pharmacological investigations. These studies have revealed its noteworthy antioxidant, anti-inflammatory, memory-enhancing, neuroprotective, anti-tumor, and various other pharmacological properties. While verbascoside exhibits favorable antioxidant effects, its precise mechanism of action in ameliorating osteoporosis through the treatment of oxidative stress remains unclear.

Methods

This study employed CCK8, ALP, ELISA, and ROS staining techniques to examine the osteoporotic effects of verbascoside on zebrafish and MC3T3-E1 cells. Additionally, this study aimed to investigate the molecular mechanism by which verbascoside improves osteoporosis by mitigating oxidative stress. To identify the common targets of verbascoside in relation to oxidative stress and osteoporosis, network pharmacology and molecular dynamics simulation were employed. The construction of the verbascoside - oxidative stress - osteoporosis - potential target gene network aimed to identify the core targets, while the mechanism of action was elucidated through KEGG analysis, and the accuracy was confirmed by assessing the mRNA expression of the targets.

Results

experiments demonstrated that verbascoside exhibited therapeutic effects on osteoporosis and reduced ROS production in zebrafish. experiments further revealed that verbascoside enhanced the proliferation and differentiation of MC3T3-E1 cells, thereby improving the oxidative stress status of osteoblasts. Thirteen core targets and estrogen signaling pathways were identified through the application of network pharmacology. The pivotal role of the estrogen signaling pathway in facilitating the ability of verbascoside to mitigate oxidative stress-induced osteoporosis was substantiated by the modulation of target protein mRNA expression.

Conclusion

The findings underscore the considerable therapeutic potential of verbascoside in ameliorating osteoporosis through the alleviation of oxidative stress, thus establishing it as a promising compound for the treatment of this condition.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073312956240826053228
2024-09-06
2026-02-28
Loading full text...

Full text loading...

References

  1. GibreelS MohamedHG SurajAR AnilS Osseointegration of dental implants and osteoporosisCurrent Concepts in Dental Implantology - From Science to Clinical ResearchLondon IntechOpen2021
    [Google Scholar]
  2. ReidI.R. Revisiting osteoporosis guidelines.Lancet Diabetes Endocrinol.202191280580610.1016/S2213‑8587(21)00283‑7 34688355
    [Google Scholar]
  3. HajamY.A. RaniR. GanieS.Y. SheikhT.A. JavaidD. QadriS.S. PramodhS. AlsulimaniA. AlkhananiM.F. HarakehS. HussainA. HaqueS. ReshiM.S. Oxidative stress in human pathology and aging: Molecular mechanisms and perspectives.Cells202211355210.3390/cells11030552 35159361
    [Google Scholar]
  4. Aparicio-BautistaD.I. Becerra-CerveraA. Rivera-ParedezB. Aguilar-OrdoñezI. Ríos-CastroE. Reyes-GrajedaJ.P. SalmerónJ. Hidalgo-BravoA. Velázquez-CruzR. Label-free quantitative proteomics in serum reveals candidate biomarkers associated with low bone mineral density in Mexican postmenopausal women.Geroscience20234622177219510.1007/s11357‑023‑00977‑1 37874452
    [Google Scholar]
  5. DaW. TaoL. ZhuY. The role of osteoclast energy metabolism in the occurrence and development of osteoporosis.Front. Endocrinol.20211267538510.3389/fendo.2021.675385 34054735
    [Google Scholar]
  6. ChenC.Y. TungH.Y. TsengY.F. HuangJ.S. ShiL.S. YeY.L. Verbascoside and isoverbascoside ameliorate transforming growth factor β1-induced collagen expression by lung fibroblasts through Smad/non-Smad signaling pathways.Life Sci.202230812095010.1016/j.lfs.2022.120950 36100079
    [Google Scholar]
  7. LiuY. HuangW. ZhuY. ZhaoT. XiaoF. WangY. LuB. Acteoside, the main bioactive compound in Osmanthus fragrans flowers, palliates experimental colitis in mice by regulating the gut microbiota.J. Agric. Food Chem.20227041148116210.1021/acs.jafc.1c07583 35073073
    [Google Scholar]
  8. LiuC. WangL. ZhuR. LiuH. MaR. ChenB. LiL. GuoY. JiaQ. ShiS. ZhaoD. MoF. ZhaoB. NiuJ. FuM. OrekhovA.N. BrömmeD. GaoS. ZhangD. Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.Osteoporos. Int.201930249150510.1007/s00198‑018‑4670‑y 30151623
    [Google Scholar]
  9. LiuC. WangL. ZhuR. LiuH. MaR. ChenB. LiL. GuoY. JiaQ. ShiS. ZhaoD. MoF. ZhaoB. NiuJ. FuM. OrekhovA.N. BrömmeD. GaoS. ZhangD. Correction to: Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.Osteoporos. Int.20193071537154010.1007/s00198‑019‑05028‑0 31214751
    [Google Scholar]
  10. SongZ. ZhangH. JiangY. ZhaoR. PeiX. NingH. ChenH. PanJ. GongY. SongM. WangW. Study on complications of osteoporosis based on network pharmacology.Front. Genet.20221394109810.3389/fgene.2022.941098 36246605
    [Google Scholar]
  11. LiX. LiuZ. LiaoJ. ChenQ. LuX. FanX. Network pharmacology approaches for research of Traditional Chinese Medicines.Chin. J. Nat. Med.202321532333210.1016/S1875‑5364(23)60429‑7 37245871
    [Google Scholar]
  12. LuoL. GuanZ. JinX. GuanZ. JiangY. Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification.Mol. Med.20232913610.1186/s10020‑023‑00625‑6 36941586
    [Google Scholar]
  13. AdamiG. FassioA. RossiniM. CaimmiC. GiolloA. OrsoliniG. ViapianaO. GattiD. Osteoporosis in rheumatic diseases.Int. J. Mol. Sci.20192023586710.3390/ijms20235867 31766755
    [Google Scholar]
  14. MohamadN.V. Ima-NirwanaS. ChinK.Y. Are oxidative stress and inflammation mediators of bone loss due to estrogen deficiency? A review of current evidence.Endocr. Metab. Immune Disord. Drug Targets20202091478148710.2174/1871530320666200604160614 32496996
    [Google Scholar]
  15. YuB. WangC.Y. Osteoporosis and periodontal diseases – An update on their association and mechanistic links.Periodontol. 200020228919911310.1111/prd.12422 35244945
    [Google Scholar]
  16. ZhaoF. GuoL. WangX. ZhangY. Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: A systematic review and meta-analysis.Arch. Osteoporos.2021161410.1007/s11657‑020‑00854‑w 33400044
    [Google Scholar]
  17. TaoZ.S. LiT.L. WeiS. Probucol promotes osteoblasts differentiation and prevents osteoporosis development through reducing oxidative stress.Mol. Med.20222817510.1186/s10020‑022‑00503‑7 35764958
    [Google Scholar]
  18. NigroO. TuziA. TartaroT. GiaquintoA. ValliniI. PinottiG. Biological effects of verbascoside and its anti-inflammatory activity on oral mucositis: A review of the literature.Anticancer Drugs20203111510.1097/CAD.0000000000000818 31609769
    [Google Scholar]
  19. Pierre LuhataL. UsukiT. Free radical scavenging activities of verbascoside and isoverbascoside from the leaves of Odontonema strictum (Acanthaceae).Bioorg. Med. Chem. Lett.20225912852810.1016/j.bmcl.2022.128528 34999211
    [Google Scholar]
  20. BellaviaD. DimarcoE. CostaV. CarinaV. De LucaA. RaimondiL. FiniM. GentileC. CaradonnaF. GiavaresiG. Flavonoids in bone erosive diseases: Perspectives in osteoporosis treatment.Trends Endocrinol. Metab.2021322769410.1016/j.tem.2020.11.007 33288387
    [Google Scholar]
  21. LiuM. XieW. ZhengW. YinD. LuoR. GuoF. [Targeted binding of estradiol with ESR1 promotes proliferation of human chondrocytes in vitro by inhibiting activation of ERK signaling pathway]Nan Fang Yi Ke Da Xue Xue Bao2019392134143 30890499
    [Google Scholar]
  22. ParkO.J. KwonY. KimJ. ParkC. YunC.H. HanS.H. Muramyl dipeptide alleviates estrogen deficiency‐induced osteoporosis through canonical WNT signaling.J. Pathol.2023260213714710.1002/path.6069 36811349
    [Google Scholar]
  23. DamaA. BaggioC. BoscaroC. AlbieroM. CignarellaA. Estrogen receptor functions and pathways at the vascular immune interface.Int. J. Mol. Sci.2021228425410.3390/ijms22084254 33923905
    [Google Scholar]
  24. ZhangD. DuJ. YuM. SuoL. Ginsenoside Rb1 prevents osteoporosis via the AHR/PRELP/NF-κB signaling axis.Phytomedicine202210415420510.1016/j.phymed.2022.154205 35716470
    [Google Scholar]
  25. WangN. XuP. WuR. WangX. WangY. ShouD. ZhangY. Timosaponin BII improved osteoporosis caused by hyperglycemia through promoting autophagy of osteoblasts via suppressing the mTOR/NFκB signaling pathway.Free Radic. Biol. Med.202117111212310.1016/j.freeradbiomed.2021.05.014 33992678
    [Google Scholar]
  26. WeiZ. LiT. SunY. SuH. ZengY. WangQ. KuangH. Daturataturin A, a withanolide inDATURA METEL L., induces HACAT autophagy through the PI3K‐AKT‐MTOR signaling pathway.Phytother. Res.20213531546155810.1002/ptr.6921 33560581
    [Google Scholar]
  27. ZhaoG. ShiX. SunZ. ZhaoP. LuZ. PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway.Acta Biochim. Biophys. Sin. (Shanghai)202153121602161310.1093/abbs/gmab143 34718369
    [Google Scholar]
  28. ZhuC. ShenS. ZhangS. HuangM. ZhangL. ChenX. Autophagy in bone remodeling: A regulator of oxidative stress.Front. Endocrinol.20221389863410.3389/fendo.2022.898634 35846332
    [Google Scholar]
  29. ChenK. GaoP. LiZ. DaiA. YangM. ChenS. SuJ. DengZ. LiL. Forkhead box O signaling pathway in skeletal muscle atrophy.Am. J. Pathol.2022192121648165710.1016/j.ajpath.2022.09.003 36174679
    [Google Scholar]
  30. Orea-SoufiA. PaikJ. BragançaJ. DonlonT.A. WillcoxB.J. LinkW. FOXO transcription factors as therapeutic targets in human diseases.Trends Pharmacol. Sci.202243121070108410.1016/j.tips.2022.09.010 36280450
    [Google Scholar]
  31. WenJ. XiongK. AiliA. WangH. ZhuY. YuZ. YaoX. JiangP. XueL. WangJ. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.Theranostics202010125322534010.7150/thno.42371 32373215
    [Google Scholar]
  32. ParkJ.H. ChoD.H. HwangY.J. LeeJ.Y. LeeH.J. JoI. Activation of ATM/Akt/CREB/eNOS signaling axis by aphidicolin increases NO production and vessel relaxation in endothelial cells and rat aortas.Biomol. Ther. (Seoul)202028654956010.4062/biomolther.2020.007 32394671
    [Google Scholar]
  33. SunX. WeiB. PengZ. FuQ. WangC. ZhenJ. SunJ. Protective effects of Dipsacus asper polysaccharide on osteoporosis in vivo by regulating RANKL/RANK/OPG/VEGF and PI3K/Akt/eNOS pathway.Int. J. Biol. Macromol.201912957958710.1016/j.ijbiomac.2019.02.022 30735778
    [Google Scholar]
  34. DowsettL. HigginsE. AlanaziS. AlshuwayerN.A. LeiperF.C. LeiperJ. ADMA: A key player in the relationship between vascular dysfunction and inflammation in atherosclerosis.J. Clin. Med.202099302610.3390/jcm9093026 32962225
    [Google Scholar]
  35. TesfamariamB. Targeting heme-oxidized soluble guanylate cyclase to promote osteoblast function.Drug Discov. Today202025242242910.1016/j.drudis.2019.12.004 31846712
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073312956240826053228
Loading
/content/journals/cchts/10.2174/0113862073312956240826053228
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test